A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
P53 Germline Mutations and Therapy-related Myelodysplastic Syndrome
2005
Internal medicine (Tokyo. 1992)
Mutations of the p53 tumor-suppressor gene are important in the multistep process of malignant transformation. Whereas germline p53 mutations such as those observed in cancer-prone families including Li-Fraumeni syndrome (LFS) and LFS-like syndrome (LFL), are very rare; somatically acquired p53 mutations are observed in more than 50% of patients with solid tumors (1, 2). The type and location of p53 germ-line mutations observed in cancer-prone families (LFS/LFL and a family history of cancer:
doi:10.2169/internalmedicine.44.406
pmid:15942083
fatcat:pcmhbei3hndqvj7uykhf7qmffy